Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 603 44 020.7 |
96 | EP file number | EAKZ | 09 01 1388.7 |
97 | EP publication number | EPN | 2130536 |
54 | Designation/title | TI | N3-alkylierte Benzimidazolderivate als MEK-Inhibitoren |
51 | IPC main class | ICM (ICMV) | A61K 31/4184 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07D 235/04 (2006.01), C07D 235/06 (2006.01), A61P 35/00 (2006.01) |
22 | DE application date | DAT | Mar 13, 2003 |
96 | EP application date | EAT | Mar 13, 2003 |
43 | Date of first publication | OT | Dec 9, 2009 |
| Date of publication of grant | PET | May 8, 2013 |
71/73 | Applicant/owner | INH | Array Biopharma Inc., Boulder, Col., US; AstraZeneca AB, Södertälje, SE |
72 | Inventor | IN | Lyssikatos, Joseph, P., BoulderCO 80301, US; Wallace, Eli, M., LyonsCO 80540, US; Hurley, Brian, T., BoulderColorado 80301, US; Marlow, Allison, L., BoulderColorado 80301, US |
74 | Representative | VTR | Grünecker Patent- und Rechtsanwälte PartG mbB, 80802 München, DE |
| Address for service | | Grünecker Patent- und Rechtsanwälte PartG mbB, 80802 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 364007 P Mar 13, 2002
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002130536 Searchable text:
EP000002130536 Original document:
EP000002130536B1 Searchable text:
EP000002130536B1 |
43 | Date of first publication | EVT | Dec 9, 2009 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 15, 2023 (Show all update days)(Hide all update days)- May 27, 2011
- Date of the first transfer into DPMAregister
|